Product
AI AGENTS
INTELLIGENCE SUITE
API, MCP & INTEGRATION
Solutions
INDUSTRIES
USE CASES
Pricing
Resources
EXPLORE
ENGAGE
SUPPORT & SERVICES
About
Patsnap Eureka Platform
IP Search Agents
IP Drafting Agents
Engineering Agents
Find Solutions with TRIZ
Life Sciences Agents
Materials Agents
SEP Agents
Patsnap Eureka Desktop
BetaAnalytics
IP IntelligenceSynapse
Biopharma IntelligenceBio
Biosequence Search and AnalysisChemical
Chemical Structure Search and AnalysisProfessional Services
Open Platform
Developer Center
Customer Stories
Newsroom
Blog
Global Innovation Report
Glossary
Webinars & Training
User Community
R&D Benchmark Calculator
Trust and Security
PatentBench
NEWLLM
Help center
Careers
Access to over 2,000,000,000 structured data points around patents, science, litigation, and tech sectors
Innovate 75% faster at 25% less cost
Cloud or on-prem for maximum privacy and control
Trusted by more than 18,000 innovators worldwide
To use , click the vertification button in the email we sent to [email protected].
This helps keep your account secure.
You should receive it shortly. Don’t forget to check your spam folder.
Unlock professional features and history
Already have an account? Log In
To start using Patsnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Thoughtfully curated series offering valuable insights for innovation professionals
Article | Report How AnaptysBio's rosnilimab targets PD-1-high pathogenic T cells in rheumatoid arthritis — a mechanistically distinct immune tolerizing approach entering Phase III.
Article | Report Explore the low-k dielectric materials landscape for 3D IC packaging in 2026: key material classes, IPC codes, assignees, and how to navigate the IP space.
Article | Report Nuclear microreactors below 20 MWe are moving from prototype to factory production. Explore the 2026 technology landscape: KRUSTY, Holos-Quad, HALEU fuel, and manufacturing economics.
Article | Report A 2026 technology landscape of intestinal organoid disease modeling: key platforms, innovation clusters, application domains, and emerging R&D directions from 80+ records.
Article | Report Tarlatamab (Imdelltra) is expanding into limited-stage SCLC and first-line settings. Explore what the DLL3×CD3 BiTE data signals mean for SCLC drug development.
Article | Report Explore the key engineering challenges of next-generation electrochromic smart window systems—from ionic transport to large-area coating uniformity—for energy-efficient buildings.
Article | Report Explore the 2026 fuel cell bipolar plate materials landscape: graphite composites, metallic plates, coatings, and IP strategy insights from PatSnap Eureka.
Article | Report Talquetamab's GPRC5D mechanism, Phase III combination strategies, and competitive positioning against BCMA-targeted bispecific antibodies in relapsed/refractory myeloma.
Article | Report Hard vs. soft real-time requirements explained for safety-critical embedded control system design. Understand timing constraints, RTOS scheduling, and IEC 61508.
Article | Report Explore the 2026 lithium-sulfur battery materials landscape: cathode host architectures, electrolyte design strategies, and what the patent data reveals.
Article | Report A 2026 technology landscape of autonomous vehicle lidar calibration: key patent clusters, assignees, emerging directions, and strategic IP implications across 70+ records.
Article | Report How teclistamab (Tecvayli) and talquetamab stack up in later-line myeloma: patent strategy, BCMA vs GPRC5D targeting, and J&J combination data decoded.
Article | Report Explore the key engineering barriers to reliable high-cycle fatigue performance in additively manufactured Inconel components — from porosity to residual stress.
Article | Report Explore the 2026 PFAS-free fluoropolymer alternative landscape for coatings and membranes: regulatory drivers, material innovation trends, and patent intelligence.
Article | Report A 2026 landscape of mRNA therapeutic stability technology: chemical modification, LNP delivery, lyophilization, circular mRNA, and emerging IP frontiers mapped from patent and literature evidence.